SCHEMBL530073

SCHEMBL530073

CN(C)CC1CCN(c2c(CC=O)cnc3ccc(Br)cc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MELK Q14680 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL529339 0.81 MELK (0.62) MELK
SCHEMBL529574 0.79 MELK (0.73) MELK
SCHEMBL530165 0.77 MELK (0.57) MELK
SCHEMBL528900 0.74 NCF1 (0.58) MELK
SCHEMBL17434907 0.72 MELK (0.49) MELK
SCHEMBL17434906 0.72 MELK (0.49) MELK
SCHEMBL528825 0.71 MELK (0.49) MELK
SCHEMBL529374 0.71 MELK (0.50) MELK
SCHEMBL529070 0.70 MELK (0.49) MELK
SCHEMBL529071 0.70 MELK (0.49) MELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2597955-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME OncoTherapy Science, Inc. (JP) 2013-06-05 EP disclosed
WO-2012016082-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2012-02-02 WO disclosed